科研之友ScholarMate
免费注册
首页 论文 论文详情
赞 收藏 引用

A Phase 1/2 Multi-Center, Randomized, Open Label Dose Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of Pomalidomide Alone or In Combination with Low-Dose Dexamethasone In Patients with Relapsed and Refractory Multiple Myeloma Who Have Received Prior Treatment That Includes Lenalidomide and Bortezomib

作者：Richardson Paul G; Siegel David; Baz Rachid; Kelley Susan L; Munshi Nikhil C; Sullivan Daniel; Alsina Melissa; Doss Deborah; McBride Laura; Larkins Gail; Lizza Maria; Yu Xin; Zaki Mohamed; Jacques Christian J; Anderson Kenneth C
来源：52nd Annual Meeting of the American-Society-of-Hematology (ASH), 2010-12-04 to 2010-12-07.
  • 出版日期2010-11-19
收藏 分享 被引(4) 浏览
更新时间：2018-02-09 16:04